speb/financial-data huggingface dataset:
ALYA.TO income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -9469000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -2164000.00
ALYA.TO cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -72000.00
ALYA.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 7712000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Net PPE: 6244000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 6244000.00
ALYA.TO cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -1417000.00
ALYA.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -409000.00
ALYA.TO cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -7712000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Net Tangible Assets: -72002000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -72002000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Non Current Accounts Receivable: 13963000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 13963000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Non Current Deferred Assets: 5274000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 5274000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Non Current Deferred Liabilities: 9584000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 9584000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 5274000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 5274000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 9584000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 9584000.00
ALYA.TO income_statement (annual, 2026-03-31) — Normalized EBITDA: 39125000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 10979000.00
ALYA.TO income_statement (annual, 2026-03-31) — Normalized Income: -11245400.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Normalized Income: -3403000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Notes Receivable: 3277000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Notes Receivable: 3277000.00
ALYA.TO cash_flow (annual, 2026-03-31) — Operating Cash Flow: 25827000.00
ALYA.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 3472000.00
ALYA.TO cash_flow (annual, 2026-03-31) — Operating Gains Losses: 433000.00
ALYA.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -1454000.00
ALYA.TO income_statement (annual, 2026-03-31) — Operating Income: 17793000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Operating Income: 6143000.00
ALYA.TO income_statement (annual, 2026-03-31) — Operating Revenue: 477388000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 113776000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 96867123.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 96867123.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Other Current Borrowings: 8478000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 8478000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 3185000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 3185000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Other Equity Adjustments: 6078000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 6078000.00
ALYA.TO income_statement (annual, 2026-03-31) — Other Gand A: 122152000.00
ALYA.TO income_statement (annual, 2026-03-31) — Other Income Expense: -45886000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: -8790000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 55316000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 55316000.00
ALYA.TO cash_flow (annual, 2026-03-31) — Other Non Cash Items: 7381000.00
ALYA.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 5162000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1040000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1040000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 2704000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 2704000.00
ALYA.TO income_statement (annual, 2026-03-31) — Other Operating Expenses: -12840000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Other Receivables: 32695000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 32695000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Payables: 39137000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Payables: 39137000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 39137000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 39137000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 35580000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 35580000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Prepaid Assets: 8514000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 8514000.00
ALYA.TO income_statement (annual, 2026-03-31) — Pretax Income: -37562000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Pretax Income: -4811000.00
ALYA.TO cash_flow (annual, 2026-03-31) — Proceeds From Stock Option Exercised: 100000.00
ALYA.TO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Properties: 0.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
ALYA.TO cash_flow (annual, 2026-03-31) — Purchase Of Business: -11881000.00
ALYA.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -1039000.00
ALYA.TO cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -316000.00
ALYA.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -38000.00
ALYA.TO cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1417000.00
ALYA.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -409000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Receivables: 116896000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 116896000.00
ALYA.TO income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 328148000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 83623000.00
ALYA.TO income_statement (annual, 2026-03-31) — Reconciled Depreciation: 22135000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 5027000.00
ALYA.TO cash_flow (annual, 2026-03-31) — Repayment Of Debt: -62647000.00
ALYA.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -12392000.00
ALYA.TO cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: -5413000.00
ALYA.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -4599000.00
ALYA.TO income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: 4084000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 6294000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Retained Earnings: -186869000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -186869000.00
ALYA.TO income_statement (annual, 2026-03-31) — Salaries And Wages: 0.00
ALYA.TO income_statement (annual, 2026-03-31) — Selling General And Administration: 122152000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 31823000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Share Issued: 96867123.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 96867123.00
ALYA.TO cash_flow (annual, 2026-03-31) — Short Term Debt Payments: -7712000.00
ALYA.TO income_statement (annual, 2026-03-31) — Special Income Charges: -45212000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: -9394000.00
ALYA.TO cash_flow (annual, 2026-03-31) — Stock Based Compensation: 5496000.00
ALYA.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1173000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Stockholders Equity: 142691000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 142691000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Tangible Book Value: -72002000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -72002000.00
ALYA.TO income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -18354400.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -3516000.00
ALYA.TO income_statement (annual, 2026-03-31) — Tax Provision: 1215000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 3866000.00
ALYA.TO income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
ALYA.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
ALYA.TO balance_sheet (annual, 2026-03-31) — Taxes Receivable: 8330000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 8330000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Total Assets: 381958000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 381958000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Total Capitalization: 255109000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 255109000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Total Debt: 126717000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 126717000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 142691000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 142691000.00
ALYA.TO income_statement (annual, 2026-03-31) — Total Expenses: 459595000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 107633000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 239267000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 239267000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 243715000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 243715000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 128941000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 128941000.00
ALYA.TO income_statement (annual, 2026-03-31) — Total Operating Income As Reported: -28093000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -2647000.00
ALYA.TO income_statement (annual, 2026-03-31) — Total Other Finance Cost: 1193000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 231000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Total Tax Payable: 1662000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 1662000.00
ALYA.TO income_statement (annual, 2026-03-31) — Total Unusual Items: -45886000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -8790000.00
ALYA.TO income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -45886000.00
ALYA.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -8790000.00
ALYA.TO balance_sheet (annual, 2026-03-31) — Working Capital: 27917000.00
ALYA.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 27917000.00
ALZ.TO balance_sheet (annual, 2021-12-31) — Accounts Payable: 12540000000.00
ALZ.TO balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 2790000000.00
ALZ.TO balance_sheet (annual, 2021-12-31) — Held To Maturity Securities: 2749000000.00
ALZ.TO balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 2790000000.00
ALZ.TO balance_sheet (annual, 2021-12-31) — Net Debt: 11935000000.00
ALZ.TO balance_sheet (annual, 2021-12-31) — Other Receivables: 5716000000.00
ALZ.TO cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 11000000.00
ALZ.TO balance_sheet (annual, 2021-12-31) — Trading Securities: 771000000.00
ALZ.TO income_statement (annual, 2021-12-31) — Write Off: 0.00
ALZ.TO income_statement (annual, 2022-12-31) — +Total Revenue: 79860000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 11825000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 7098000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -12190000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 27732000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Amortization: 323000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 7870000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Average Dilution Earnings: -13000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 8059770986.00
ALZ.TO income_statement (annual, 2022-12-31) — Basic EPS: 0.78
ALZ.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 24036000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -1618000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 2740000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 1170000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 22896000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 567788000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -4870000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 180000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 418000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: -6800000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -1407000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Common Stock: 1170000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -4870000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 54415000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
ALZ.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -1311000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Depreciation: 2179000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2179000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 323000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 6586000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 8088991576.00
ALZ.TO income_statement (annual, 2022-12-31) — Diluted EPS: 0.78
ALZ.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 6289000000.00
ALZ.TO income_statement (annual, 2022-12-31) — EBIT: 11087000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 268000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — End Cash Position: 22896000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Financial Assets: 9547000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 77951000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -4367000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 16334000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 23782000000.00
ALZ.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 11173000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Goodwill: 16255000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 18442000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 24977000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 2867000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Interest Expense: 1438000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1438000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Interest Income: 24801000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 83913000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -14992000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Investment Properties: 25861000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 95368000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 662697000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
ALZ.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 8823000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 2740000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 29498000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 29498000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 8823000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -6455000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 22437000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Long Term Provisions: 2963000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 10716000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Minority Interest: 4320000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Minority Interests: -435000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -1311000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -1311000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Net Debt: 6602000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Net Income: 6421000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 6302000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 6856000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 6421000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 6421000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 6856000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 6856000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Net Interest Income: -1438000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Net Investment Properties Purchase And Sale: -1169000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 10666000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 2368000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 2368000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -1438000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -104000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 98000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Net PPE: 12787000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1398000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Net Policyholder Benefits And Claims: 33833000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 35973000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 610000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 6369000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 2158000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 11455000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Normalized Income: 7095259000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 17952000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Operating Revenue: 79860000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 401589162.00
ALZ.TO cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: -1000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Other Equity Interest: 4843000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Other Income Expense: 3728000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 2187000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: -1732000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 424000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Other Payable: 804000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Other Properties: 9991000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Other Receivables: 5758000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 544892000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Other Special Charges: 0.00
ALZ.TO income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 119000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Payables: 4662000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 921000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Pretax Income: 9664000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Properties: 4270000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 5000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Purchase Of Business: -2687000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -264286000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment Properties: -1771000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1618000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2179000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -6455000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -1311000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 951000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: 29687000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Sale Of Business: 1376000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Sale Of Investment: 274952000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Sale Of Investment Properties: 602000000.00
ALZ.TO cash_flow (annual, 2022-12-31) — Sale Of PPE: 220000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 11173000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Share Issued: 403313996.00
ALZ.TO income_statement (annual, 2022-12-31) — Special Income Charges: -951000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 54415000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 35973000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -276741000.00
ALZ.TO income_statement (annual, 2022-12-31) — Tax Provision: 2808000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.29
ALZ.TO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 4870000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Total Assets: 935897000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 83913000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Total Debt: 29498000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 58735000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Total Expenses: 70195000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 877162000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 3858000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Total Unusual Items: -951000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -951000000.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 1724834.00
ALZ.TO balance_sheet (annual, 2022-12-31) — Treasury Stock: 333000000.00
ALZ.TO income_statement (annual, 2022-12-31) — Write Off: 436000000.00
ALZ.TO income_statement (annual, 2023-12-31) — +Total Revenue: 119667000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 7943000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -13017000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 27732000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Amortization: 319000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 8829000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Average Dilution Earnings: -6000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 7888477478.00
ALZ.TO income_statement (annual, 2023-12-31) — Basic EPS: 1.06
ALZ.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 22896000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -2140000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 1170000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 29209000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 589942000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -4931000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 3703000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 13000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: 4360000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Changes In Cash: 6731000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Common Stock: 1170000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -4931000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 58239000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
ALZ.TO cash_flow (annual, 2023-12-31) — Common Stock Payments: -2202000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Depreciation: 2272000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2272000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 319000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 10194000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 7890983834.00
ALZ.TO income_statement (annual, 2023-12-31) — Diluted EPS: 1.06
ALZ.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 8393000000.00
ALZ.TO income_statement (annual, 2023-12-31) — EBIT: 12213000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -468000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — End Cash Position: 29210000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Financial Assets: 15114000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 89162000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -5724000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: 22322000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 7254000000.00
ALZ.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 4747000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Goodwill: 16621000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 18649000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 26087000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Interest Expense: 631000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 631000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Interest Income: 25386000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 88222000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -12007000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Investment Properties: 23924000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 113105000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Investments And Advances: 695025000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
ALZ.TO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 6869000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Long Term Debt: 29983000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 29983000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 6869000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -5619000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 21187000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Long Term Provisions: 2800000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 11286000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Minority Interest: 3321000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Minority Interests: -491000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -858000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -2202000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Net Debt: 774000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Net Income: 8541000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 8399000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 9032000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 8541000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 8541000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 9032000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 9032000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Net Interest Income: -631000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: -446000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -8523000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 1250000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 1250000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -631000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 560000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -228000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Net PPE: 13070000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1952000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Net Policyholder Benefits And Claims: 34643000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 39590000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 672000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 5992000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 2124000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 12288000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Normalized Income: 8984040000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 24462000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Operating Revenue: 119667000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 391458589.00
ALZ.TO cash_flow (annual, 2023-12-31) — Other Cash Adjustment Outside Changein Cash: 51000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Other Equity Interest: 4764000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Other Income Expense: -1980000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 2028000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2131000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Other Operating Expenses: 46000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Other Payable: 873000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Other Properties: 10619000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 560733000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Other Special Charges: 0.00
ALZ.TO income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 142000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Payables: 5214000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 788000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Pretax Income: 11582000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Properties: 4182000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Purchase Of Business: -1197000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -214119000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment Properties: -1510000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -2140000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2272000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -5619000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -2202000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 568000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: 30502000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Sale Of Business: 339000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 205596000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 1064000000.00
ALZ.TO cash_flow (annual, 2023-12-31) — Sale Of PPE: 188000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 4747000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Share Issued: 391718983.00
ALZ.TO income_statement (annual, 2023-12-31) — Special Income Charges: -568000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 58239000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 39590000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -124960000.00
ALZ.TO income_statement (annual, 2023-12-31) — Tax Provision: 2550000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.22
ALZ.TO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 5414000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Total Assets: 983174000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 88222000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Total Debt: 29983000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 61560000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Total Expenses: 108087000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 921614000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 4341000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Total Unusual Items: -568000000.00
ALZ.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -568000000.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 260394.00
ALZ.TO balance_sheet (annual, 2023-12-31) — Treasury Stock: 38000000.00
ALZ.TO income_statement (annual, 2024-12-31) — +Total Revenue: 139947000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 8076000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 8076000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -14490000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -14490000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 27732000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Amortization: 296000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 10172000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 10172000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Average Dilution Earnings: -5000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 7734612027.00
ALZ.TO income_statement (quarterly, 2024-12-31) — Basic Average Shares: 7682658774.00
ALZ.TO income_statement (annual, 2024-12-31) — Basic EPS: 1.27
ALZ.TO income_statement (quarterly, 2024-12-31) — Basic EPS: 0.32
ALZ.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 29210000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -1915000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 2592000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 2592000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 1170000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 31637000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 606519000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -5751000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 13212000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 623000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: 16799000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 1864000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Common Stock: 1170000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -5751000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 60287000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
ALZ.TO cash_flow (annual, 2024-12-31) — Common Stock Payments: -1500000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 463000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 463000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 463000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 463000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Depreciation: 2154000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2154000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 296000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 14242000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 14242000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 7737018631.00
ALZ.TO income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 7721572220.00
ALZ.TO income_statement (annual, 2024-12-31) — Diluted EPS: 1.26
ALZ.TO income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.32
ALZ.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 9783000000.00
ALZ.TO income_statement (annual, 2024-12-31) — EBIT: 14778000000.00
ALZ.TO income_statement (quarterly, 2024-12-31) — EBIT: 3722000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 426000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — End Cash Position: 31637000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Financial Assets: 18222000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Financial Assets: 18222000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 101827000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 101827000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -4364000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 29988000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 4434000000.00
ALZ.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 5160000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Goodwill: 17062000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Goodwill: 17062000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 19125000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 27671000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Gross PPE: 27671000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Interest Expense: 762000000.00
ALZ.TO income_statement (quarterly, 2024-12-31) — Interest Expense: 204000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 762000000.00
ALZ.TO income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 204000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Interest Income: 28019000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 92534000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -25675000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Investment Properties: 22496000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Investment Properties: 22496000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 130221000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 727409000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
ALZ.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 9206000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 2129000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 2129000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Long Term Debt: 32247000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 23117000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 34376000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 34376000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 9206000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -6087000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 22306000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 22306000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Long Term Provisions: 3212000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 3212000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 12366000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 12366000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Minority Interest: 3789000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Minority Interests: -609000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -725000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -1500000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Net Debt: 610000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Net Income: 9931000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 9788000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 10540000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 9931000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 9931000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 10540000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 10540000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Net Interest Income: -762000000.00
ALZ.TO income_statement (quarterly, 2024-12-31) — Net Interest Income: -204000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: -48000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -23795000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 3119000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 3119000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -762000000.00
ALZ.TO income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -204000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 172000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 536000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Net PPE: 13181000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Net PPE: 13181000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1643000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Net Policyholder Benefits And Claims: 37849000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 41162000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 743000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 743000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 6055000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 2257000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 12289000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 12289000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Normalized Income: 10457400000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 31903000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Operating Revenue: 139947000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 385919437.00
ALZ.TO cash_flow (annual, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: 137000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Other Equity Interest: 4916000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Other Income Expense: 3833000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 2063000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -4617000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: -89000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Other Payable: 917000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Other Payable: 917000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Other Properties: 10987000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 10987000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 574882000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 574882000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Other Special Charges: 0.00
ALZ.TO income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 143000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Payables: 5768000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Payables: 5768000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 849000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 849000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Pretax Income: 14016000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Properties: 4318000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Properties: 4318000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Purchase Of Business: -1189000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -281487000000.00